1. Home
  2. OPAL vs GNLX Comparison

OPAL vs GNLX Comparison

Compare OPAL & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPAL Fuels Inc.

OPAL

OPAL Fuels Inc.

HOLD

Current Price

$2.06

Market Cap

78.3M

Sector

Utilities

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$4.17

Market Cap

202.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPAL
GNLX
Founded
1998
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.3M
202.4M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
OPAL
GNLX
Price
$2.06
$4.17
Analyst Decision
Sell
Strong Buy
Analyst Count
4
4
Target Price
$2.81
$19.75
AVG Volume (30 Days)
191.8K
165.6K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$329,243,000.00
N/A
Revenue This Year
$17.15
N/A
Revenue Next Year
$22.04
N/A
P/E Ratio
$92.83
N/A
Revenue Growth
7.26
N/A
52 Week Low
$1.26
$1.99
52 Week High
$4.08
$8.54

Technical Indicators

Market Signals
Indicator
OPAL
GNLX
Relative Strength Index (RSI) 38.19 35.47
Support Level $2.50 $4.00
Resistance Level $2.74 $4.37
Average True Range (ATR) 0.17 0.32
MACD -0.05 -0.01
Stochastic Oscillator 5.67 14.76

Price Performance

Historical Comparison
OPAL
GNLX

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: